| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.0081 |
0.9 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |